215 related articles for article (PubMed ID: 19209043)
1. Evaluation of resource utilization and cost burden before and after an employer-based migraine education program.
Page MJ; Paramore LC; Doshi D; Rupnow MF
J Occup Environ Med; 2009 Feb; 51(2):213-20. PubMed ID: 19209043
[TBL] [Abstract][Full Text] [Related]
2. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
3. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
5. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Workplace-Based Migraine Education Program.
Burton WN; Chen CY; Li X; McCluskey M; Erickson D; Schultz AB
J Occup Environ Med; 2016 Aug; 58(8):790-5. PubMed ID: 27206133
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
[TBL] [Abstract][Full Text] [Related]
8. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
Wong LP; Alias H; Bhoo-Pathy N; Chung I; Chong YC; Kalra S; Shah ZUBS
J Headache Pain; 2020 Jun; 21(1):68. PubMed ID: 32513174
[TBL] [Abstract][Full Text] [Related]
9. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
10. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
11. Results of a Virtual Migraine Education Program in an Employed Population.
Burton WN; Schultz AB; Shepherd ME; McCluskey M; Hines D
J Occup Environ Med; 2022 Jan; 64(1):52-57. PubMed ID: 34310543
[TBL] [Abstract][Full Text] [Related]
12. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
Shimizu T; Sakai F; Miyake H; Sone T; Sato M; Tanabe S; Azuma Y; Dodick DW
J Headache Pain; 2021 Apr; 22(1):29. PubMed ID: 33882816
[TBL] [Abstract][Full Text] [Related]
13. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
Lambert J; Carides GW; Meloche JP; Gerth WC; Marentette MA
Can J Clin Pharmacol; 2002; 9(3):158-64. PubMed ID: 12422253
[TBL] [Abstract][Full Text] [Related]
14. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
Lublóy Á
BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
[TBL] [Abstract][Full Text] [Related]
17. Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
Gerth WC; Sarma S; Hu XH; Silberstein SD
J Occup Environ Med; 2004 Jan; 46(1):48-54. PubMed ID: 14724478
[TBL] [Abstract][Full Text] [Related]
18. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
[TBL] [Abstract][Full Text] [Related]
19. Impact of a migraine management program on improving health outcomes.
Campinha-Bacote DL; Kendle JB; Jones C; Callicoat D; Webert A; Stoukides CA; Kaul AF
Dis Manag; 2005 Dec; 8(6):382-91. PubMed ID: 16351556
[TBL] [Abstract][Full Text] [Related]
20. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
